FDA rejects Ocular Therapeutix post-operative eye pain treatment
July 25, 2016 at 08:33 AM EDT
July 25 (Reuters) - Drug developer Ocular Therapeutix Inc said the U.S. Food and Drug Administration had denied approval for its treatment for post-operative eye pain.